Beyond Statins: Lipid Management to Reduce Cardiovascular Risk

Author:

Schuck Robert N.1,Mendys Philip M.23,Simpson Ross J.2

Affiliation:

1. Division of Pharmacotherapy and Experimental Therapeutics; UNC Eshelman School of Pharmacy; University of North Carolina; Chapel Hill North Carolina

2. Division of Cardiology; School of Medicine; University of North Carolina; Chapel Hill North Carolina

3. Pfizer, U.S. Medical Affairs and Division of Cardiology; Chapel Hill North Carolina

Publisher

Wiley

Subject

Pharmacology (medical)

Reference69 articles.

1. Heart disease and stroke statistics-2012 update: a report from the American Heart Association;Roger;Circulation,2012

2. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease;Pekkanen;N Engl J Med,1990

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group;Lancet,1994

5. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group;Shepherd;N Engl J Med,1995

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3